Search results
Results from the WOW.Com Content Network
Botulinum toxin, or botulinum neurotoxin (commonly called botox), is a highly potent neurotoxic protein produced by the bacterium Clostridium botulinum and related species. [23] It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction , thus causing flaccid paralysis . [ 24 ]
Average wholesale price. In the United States, the average wholesale price ( AWP) is a prescription drug term referring to the average price for medications offered at the wholesale level. [ 1] The metric was originally intended to convey real pricing information to third-party payers, including government prescription drug programs.
Clostridium botulinum. van Ermengem, 1896. Clostridium botulinum is a gram-positive, [ 1] rod-shaped, anaerobic, spore-forming, motile bacterium with the ability to produce botulinum toxin, which is a neurotoxin. [ 2][ 3] C. botulinum is a diverse group of pathogenic bacteria. Initially, they were grouped together by their ability to produce ...
Sources say the pharmaceutical company that manufactures Botox, Allergan, charges providers around $6-7 per unit, making the average patient cost more like $10-15 per unit (with metropolitan areas ...
The maker of Botox Allergan will be bought by Abbvie in a cash and stock deal valued at about $63 billion. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Connor Browne, a portfolio ...
Newsvendor model. The newsvendor (or newsboy or single-period[ 1] or salvageable) model is a mathematical model in operations management and applied economics used to determine optimal inventory levels. It is (typically) characterized by fixed prices and uncertain demand for a perishable product. If the inventory level is , each unit of demand ...
“Preventative Botox involves using Botox injections before wrinkles and fine lines become deeply etched into the skin,” explains New York- and California-based dermatologist Dr. Karyn Grossman ...
Alan B. Scott. Alan Brown Scott (July 13, 1932 – December 16, 2021 [1]) was an American ophthalmologist specializing in eye muscles and their disorders, such as strabismus (eye misalignment). He is best known for his work in developing and manufacturing the drug that became known as Botox, research described as "groundbreaking" by the ASCRS. [2]